The efficacy of the Kampo medicine rikkunshito for chemotherapy-induced anorexia (RICH trial): study protocol for a randomized controlled trial
Abstract Background Cisplatin is a key drug in lung cancer therapy. However, cisplatin is also well known to induce gastrointestinal disorders, such as chemotherapy-induced nausea and vomiting, anorexia, and weight loss. These symptoms sometimes affect patients’ quality of life and make continuation...
Main Authors: | Takuya Inoue, Hironori Takagi, Yuki Owada, Yuzuru Watanabe, Takumi Yamaura, Mitsuro Fukuhara, Satoshi Muto, Naoyuki Okabe, Yuki Matsumura, Takeo Hasegawa, Jun Osugi, Mika Hoshino, Mitsunori Higuchi, Yutaka Shio, Hiroshi Yokouchi, Kenya Kanazawa, Katsuya Ohbuchi, Takahisa Fukushima, Mitsuru Munakata, Hiroyuki Suzuki |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-10-01
|
Series: | Trials |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13063-017-2227-6 |
Similar Items
-
Ghrelin Enhancer, the Latest Evidence of Rikkunshito
by: Chihiro Yamada, et al.
Published: (2021-12-01) -
Rikkunshito as a Therapeautic Agent for Functional Dyspepsia and its Prokinetic and Non-Prokinetic Effects
by: Kazumi Inokuchi, et al.
Published: (2021-06-01) -
Application of objective structured clinical examination (OSCE) for the evaluation of Kampo medicine training
by: Marie Amitani, et al.
Published: (2022-03-01) -
Kampo for the Treatment of Pain in Japan: A Review
by: Young-Chang Arai, et al.
Published: (2020-03-01) -
Rikkunshito, a ghrelin potentiator, ameliorates anorexia-cachexia syndrome
by: Naoki eFujitsuka, et al.
Published: (2014-12-01)